These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 38862157

  • 1. Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study.
    Ma J, Zhang L, Yan M, Liu Z, Xue L.
    Lupus Sci Med; 2024 Jun 10; 11(1):. PubMed ID: 38862157
    [Abstract] [Full Text] [Related]

  • 2. Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity.
    Jesus D, Larosa M, Henriques C, Matos A, Zen M, Tomé P, Alves V, Costa N, Le Guern V, Iaccarino L, Costedoat-Chalumeau N, Doria A, Inês LS.
    Ann Rheum Dis; 2021 Dec 10; 80(12):1568-1574. PubMed ID: 34407927
    [Abstract] [Full Text] [Related]

  • 3. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
    Abdelhady EI, Rabie M, Hassan RA.
    Clin Rheumatol; 2021 Nov 10; 40(11):4553-4558. PubMed ID: 34142298
    [Abstract] [Full Text] [Related]

  • 4. A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.
    Lai NS, Lu MC, Chang HH, Lo HC, Hsu CW, Huang KY, Tung CH, Hsu BB, Wu CH, Koo M.
    J Clin Med; 2021 May 15; 10(10):. PubMed ID: 34063379
    [Abstract] [Full Text] [Related]

  • 5. Association of disease activity with depression and anxiety in systemic lupus erythematosus: A comparison of SLEDAI-2K and SLE-DAS.
    Yang L, Gu B, Wang X, Ren Q, Shen M, Su D.
    Rheumatology (Oxford); 2024 Feb 01. PubMed ID: 38305645
    [Abstract] [Full Text] [Related]

  • 6. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
    Jesus D, Matos A, Henriques C, Zen M, Larosa M, Iaccarino L, Da Silva JAP, Doria A, Inês LS.
    Ann Rheum Dis; 2019 Mar 01; 78(3):365-371. PubMed ID: 30626657
    [Abstract] [Full Text] [Related]

  • 7. Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations.
    Suszek D, Górak A, Majdan M.
    Rheumatol Int; 2020 Oct 01; 40(10):1625-1629. PubMed ID: 32772131
    [Abstract] [Full Text] [Related]

  • 8. Increased frequency of hospital admissions with active systemic lupus erythematosus disease activity defined by two different disease activity indices: A cohort study.
    Wang CL, Koo M, Hsu CW, Lu MC.
    Lupus; 2023 Jun 01; 32(7):864-872. PubMed ID: 37165549
    [Abstract] [Full Text] [Related]

  • 9. Predictors of flare in SLE patients fulfilling lupus low disease activity state: a cohort study of 292 patients with 36-month follow-up.
    Cunha RN, Saraiva L, Jesus D, Doria A, da Silva JP, Inês LS.
    Rheumatology (Oxford); 2023 Nov 02; 62(11):3627-3635. PubMed ID: 36847423
    [Abstract] [Full Text] [Related]

  • 10. Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes.
    Onishi A, Tsuji H, Takase Y, Nakakubo Y, Iwasaki T, Kozuki T, Yoshida T, Shirakashi M, Onizawa H, Hiwa R, Kitagori K, Akizuki S, Nakashima R, Yoshifuji H, Tanaka M, Morinobu A.
    Rheumatology (Oxford); 2023 Dec 01; 62(12):3909-3915. PubMed ID: 36943365
    [Abstract] [Full Text] [Related]

  • 11. Increased risk of hospital admissions in patients with active systemic lupus erythematosus (SLE) classified according to two different SLE disease activity indices: a prospective cohort study.
    Lu MC, Hsu CW, Koo M, Lai NS.
    Clin Exp Rheumatol; 2023 Jul 01; 41(7):1409-1416. PubMed ID: 36377575
    [Abstract] [Full Text] [Related]

  • 12. Performance of a New Instrument for the Measurement of Systemic Lupus Erythematosus Disease Activity: The SLE-DAS.
    Koo M, Lu MC.
    Medicina (Kaunas); 2023 Nov 29; 59(12):. PubMed ID: 38138199
    [Abstract] [Full Text] [Related]

  • 13. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual.
    Chitpet P, Chaiamnuay S, Narongroeknawin P, Asavatanabodee P, Leosuthamas P, Pakchotanon R.
    Int J Rheum Dis; 2023 Dec 29; 26(12):2509-2516. PubMed ID: 37875327
    [Abstract] [Full Text] [Related]

  • 14. Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus.
    Leosuthamas P, Narongroeknawin P, Chaiamnuay S, Asavatanabodee P, Pakchotanon R.
    Int J Rheum Dis; 2023 Apr 29; 26(4):667-672. PubMed ID: 36802112
    [Abstract] [Full Text] [Related]

  • 15. Severe pneumonia in Chinese patients with systemic lupus erythematosus.
    Peng L, Wang Y, Zhao L, Chen T, Huang A.
    Lupus; 2020 Jun 29; 29(7):735-742. PubMed ID: 32403979
    [Abstract] [Full Text] [Related]

  • 16. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients.
    Nieto-Aristizábal I, Martínez T, Urbano MA, Posso-Osorio I, Plata IF, Garcia-Robledo JE, Aragón CC, Santos VA, Tobón GJ.
    Lupus; 2019 Nov 29; 28(13):1566-1570. PubMed ID: 31653191
    [Abstract] [Full Text] [Related]

  • 17. Red blood cell distribution width-to-platelet ratio as a disease activity-associated factor in systemic lupus erythematosus.
    Xie S, Chen X.
    Medicine (Baltimore); 2018 Sep 29; 97(39):e12342. PubMed ID: 30278511
    [Abstract] [Full Text] [Related]

  • 18. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G.
    Lupus; 2016 Jun 29; 25(7):719-26. PubMed ID: 26821965
    [Abstract] [Full Text] [Related]

  • 19. Application of SLE-DAS to assess subcutaneous belimumab efficacy in a cohort of systemic lupus erythematosus patients.
    Ceccarelli F, Picciariello L, Natalucci F, Moretti V, Spinelli FR, Alessandri C, Conti F.
    Clin Exp Rheumatol; 2024 Jul 29; 42(7):1491-1494. PubMed ID: 38819948
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Lima GL, Paupitz J, Aikawa NE, Takayama L, Bonfa E, Pereira RM.
    Arthritis Care Res (Hoboken); 2016 Jan 29; 68(1):91-8. PubMed ID: 25988278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.